CAJ | 학술논문

目的评价中文版脑卒中患者自我效能问卷(the stroke self-efficacy questionnaire,SSEQ)的信效度.方法将SSEQ译成中文,对300名脑卒中患者进行调查,采用SPSS 17.0和AMOS 17.0进行统计学分析.结果中文版SSEQ总量表的Cronbach's α系数为0.972,各维度的Cronbach's α为0.969、0.949,分半信度为0.905,重测信度为0.806,量表各维度间的相关系数为0.673～0.911,各维度与总量表之间的相关系数值为0.729～0.831;探索性因素分析EFA共提取2个公因素,KMO为0.953,累计贡献率82.687％;验证性因素分析CFA,模型修正后各适配指标值卡方/自由度(CMIN/DF)为1.740、拟合优度指数(GFI)为0.918、调整后适配度指数(AGFI)为0.853、渐进残差和平方根(RMSEA)为0.070、规准适配指数(NFI)为0.965、相对适配指数(RFI)为0.947、增值适配指数(IFI)为0.985、非规准适配指数(TLI)为0.977、比较适配指数(CFI)为0.985.结论中文版SSEQ具有良好的信效度,可用于脑卒中患者自我效能的评估.
목적 평개중문판뇌졸중환자자아효능문권(the stroke self-efficacy questionnaire,SSEQ)적신효도.방법 장SSEQ역성중문,대300명뇌졸중환자진행조사,채용SPSS 17.0화AMOS 17.0진행통계학분석.결과 중문판SSEQ총량표적Cronbach's α계수위0.972,각유도적Cronbach's α위0.969、0.949,분반신도위0.905,중측신도위0.806,량표각유도간적상관계수위0.673～0.911,각유도여총량표지간적상관계수치위0.729～0.831;탐색성인소분석EFA공제취2개공인소,KMO위0.953,루계공헌솔82.687％;험증성인소분석CFA,모형수정후각괄배지표치잡방/자유도(CMIN/DF)위1.740、의합우도지수(GFI)위0.918、조정후괄배도지수(AGFI)위0.853、점진잔차화평방근(RMSEA)위0.070、규준괄배지수(NFI)위0.965、상대괄배지수(RFI)위0.947、증치괄배지수(IFI)위0.985、비규준괄배지수(TLI)위0.977、비교괄배지수(CFI)위0.985.결론 중문판SSEQ구유량호적신효도,가용우뇌졸중환자자아효능적평고.
Objective To translate the English version of the stroke self-efficacy questionnaire (SSEQ) into Chinese,and to evaluate the reliability and validity of the Chinese version of SSEQ.Methods The reliability and validity of the Chinese version of SSEQ were tested among 300 stroke patients in Jinzhou city.Data were analyzed by SPSS 17.0 software and AMOS 17.0 software.Results The Cronbach's α was 0.972,the test-retest reliability coefficient was 0.806,the correlations between items and total scale ranged from 0.729 to 0.831 (P＜0.01).A two-factor model was got by exploratory factor analysis,the communalities of the items was 0.672 to 0.929,and the cunulative explained variance was 82.687 percent.The confirmatory factor analysis revealed a good model fit,and the fit indices were x2/df =1.740,GFI =0.918,AGFI =0.853,RMSEA =0.070,NFI =0.965,CFI =0.985,standardized regression weights was 0.701 to 0.984.Conclusion The Chinese version of the SSEQ is proved to be reliable and valid.It can be used to assess the self-efficacy of stroke patients in china.